Research Studies » Moderate to Severe Atopic Dermatitis in Adolescent

Moderate to Severe Atopic Dermatitis in Adolescent
A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adolescent Subjects with Moderate to Severe Atopic Dermatitis
Powered By RealTime-CTMS Clinical Trial Management System